Choosing pharmacotherapies for the COMBINE study - Process and procedures: An investigational approach to combination pharmacotherapy for the treatment of alcohol dependence

Journal of Studies on Alcohol

Volumn 66, Issue SUPPL. 15, 2005, Pages 141-147

  Swift, Robert ^a,b   Pettinati, Helen M ^a,c  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ACAMPROSATE; ALCOHOL; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CALCIUM CARBIMIDE; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; DISULFIRAM; FLUOXETINE; GABAPENTIN; IMIPRAMINE; NALMEFENE; NALTREXONE; ONDANSETRON; RITANSERIN; SEDATIVE AGENT; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIAPRIDE; TRICYCLIC ANTIDEPRESSANT AGENT; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; NARCOTIC ANTAGONIST; TAURINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; DECISION MAKING; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; HUMAN; LIVER TOXICITY; NONHUMAN; PILOT STUDY; PSYCHOSOCIAL CARE; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; ARTICLE; BEHAVIOR THERAPY; DRUG ADMINISTRATION; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RESEARCH;

ALCOHOL DETERRENTS; ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; RESEARCH; RESEARCH DESIGN; TAURINE; TREATMENT OUTCOME;

EID: 23944492902     PISSN: 0096882X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. CHICK, J., ANTON, R., CHECINSKI, K., CROOP, R., DRUMMOND, D.C., FARMER, R., LABRIOLA, D., MARSHALL, J., MONCRIEFF, J., MORGAN, M.Y., PETERS, T. AND RITSON, B. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcsm 35: 587-593, 2000.
2. COMBINE STUDY RESEARCH GROUP. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence (The COMBINE Study): A pilot feasibility study. Alcsm Clin. Exp. Res. 27: 1123-1131, 2003.
3. CROOP, R.S., FAULKNER, E.B. AND LABRIOLA, D.F. The safety profile of naltrexone in the treatment of alcoholism: Results from a multicenter usage study. The Naltrexone Usage Study Group. Arch. Gen. Psychiat. 54: 1130-1135, 1997.
4. DWYER, D.S. AND BRADLEY, R.J. Chemical properties of alcohols and their protein binding sites. Cell. Mol. Life Sci. 57: 265-275, 2000.
5. GARBUTT, J.C., WEST, S.L., CAREY, T.S., LOHR, K.N. AND CREWS, F.T. Pharmacological treatment of alcohol dependence: A review of the evidence. JAMA 281: 1318-1325, 1999.
6. JOHNSON, B.A., O'MALLEY, S.S., CIRAULO, D.A., ROACHE, J.D., CHAMBERS, R.A., SARID-SEGAL, O. AND COUPER, D. Dose-ranging kinetics and behavioral pharmacotherpy of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. J. Clin. Psychopharmacol. 23: 281-293, 2003.
7. KIEFER, F., JAHN, H., TARNASKE, T., HELWIG, H., BRIKEN, P., HOLZBACH, R., KAMPF, P., STRACKE, R., BAEHR, M., NABER, D. AND WIEDEMANN, K. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind placebo-controlled study. Arch. Gen. Psychiat. 60: 92-99, 2003.
8. KOOB, G.F. AND LE MOAL, M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129, 2001.
9. LEVINE, J. AND SCHOOLER, N.R. SAFTEE: A technique for the systematic assessment of side effects in clinical trials. Psychopharm. Bull. 22: 343-381, 1986.
10. LITTEN, R.Z. AND ALLEN, J.P. Advances in development of medications for alcoholism treatment. Psychopharmacology 139: 20-33, 1998.
11. LITTLETON, J. AND LITTLE, H. Current concepts of ethanol dependence. Addiction 89: 1397-1412, 1994.
12. MCCAUL, M.E., WAND, G.S., SULLIVAN, J., MUMFORD, G. AND QUIGLEY, J. β-Naltrexol level predicts alcohol relapse (abstract). Alcsm Clin. Exp. Res. 21 (Suppl. No. 3): 32A, 1997.
13. MARTIN, C.S., EARLEYWINE, M., MUSTY, R.E., PERRINE, M.W. AND SWIFT, R.M. Development and validation of the Biphasic Alcohol Effects Scale. Alcsm Clin. Exp. Res. 17: 140-146, 1993.
14. MASON, B.J. AND OWNBY, R.L. Acamprosate for the treatment of alcohol dependence: A review of double-blind, placebo-controlled trials. CNS Spectrums 5 (2): 58-69, 2002.
15. MONTEROSSO, J.R., FLANNERY, B.A., PETTINATI, H.M., OSLIN, D.W., RUKSTALIS, M., O'BRIEN, C.P. AND VOLPICELLI, J.R. Predicting treatment response to naltrexone: The influence of craving and family history. Amer. J. Addict. 10: 258-268, 2001.
16. MONTI, P.M., ROHSENOW, D.J., SWIFT, R.M., GULLIVER, S.B., COLBY, S.M., MUELLER, T.I., BROWN, R.A., GORDON, A., ABRAMS, D.E., NIAURA, R.S. AND ASHER, M.K. Naltrexone and cue exposure with coping and communication skills training for alcoholics: Treatment process and 1-year outcomes. Alcsm Clin. Exp. Res. 25: 1634-1647, 2001.
17. OSLIN, D.W., BERRETTINI, W., KRANZLER, H.R., PETTINATI, H., GELERNTER, J., VOLPICELLI, J.R. AND O'BRIEN, C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546-1552, 2003.
18. ROBINSON, T.E. AND BERRIDGE, K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
19. SINCLAIR, J.D. Laboratory animal research in the discovery and development of new alcoholism treatment using opioid antagonists. Scand. J. Lab. Animal Sci. 23: 379-390, 1996.
20. SPANAGEL, R., HOLTER, S.M., ALLINGHAM, K., LANDGRAF, R. AND ZIEGLGANSBERGER, W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Europ. J. Pharmacol. 305: 39-44, 1996.
21. SWIFT, R.M. Drug therapy for alcohol dependence. New Eng. J. Med. 340: 1482-1490, 1999.
22. VOLPICELLI, J.R., RHINES, K.C., RHINES, J.S., VOLPICELLI, L.A., ALTERMAN, A.I. AND O'BRIEN, C.P. Naltrexone and alcohol dependence: Role of subject compliance. Arch. Gen. Psychiat. 54: 737-743, 1997.
23. WEISS, F., LORANG, M.T., BLOOM, F.E. AND KOOB, G.F. Oral alcohol self-administration stimulates dopamine release in rat nucleus accumbens: Genetic and motivational determinants. J. Pharmacol. Exp. Ther. 267: 250-258, 1993.
24. WISE, R.A. AND BOZARTH, M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492, 1987.